Phase
Condition
Reproductive Health
Infertility
Polycystic Ovarian Syndrome
Treatment
FertyBiotic Woman Plus
Placebo
Clinical Study ID
Ages 18-38 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age:18-38 years old
Diagnosis of PCOS according to compliance with the Rotterdam criteria
BMI >= 25
Exclusion
Exclusion Criteria:
Hormonal contraceptive, insulin sensitizers such as metformin, inositols,antioxidants, vitamin supplements except folic acid, GnRH analogs, steroidal drugsor others with anti-inflammatory properties, antibiotics, probiotics, laxatives usein the 3 months prior to recruitment
Tobacco consumption in last 12 months
Endometriosis, hydrosalpinx not surgically treated, acute or chronic inflammatorydiseases, systemic immune diseases, other endocrine diseases or dysfunctions exceptfor PCOS and subclinical hypothyroidism treated with low doses of levothyroxine (egcongenital adrenal hyperplasia, Cushing's syndrome, androgen-secreting tumors,Diabetes Millitus, hyperprolactinemia, hyperglycemia), active neoplastic disease orwithout evidence of complete remission for at least 5 years,
Active participation in an active weight reduction program or hypocaloric dietduring the study period. No change in habits will be taught during the study period
Hypersensitivity to any of the components in the Fertybiotic Mujer Plus® formulation
Study Design
Study Description
Connect with a study center
Hospital Clinic
Barcelona 3128760, Barcelona 08036
SpainSite Not Available
Hospital Clinic
Barcelona, 08036
SpainSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.